Resoconti Takeda Pharmaceutical Company Limited Sapporo S.E.

Azioni

4502

JP3463000004

Mercato chiuso - Sapporo S.E. Altri mercati azionari 01:53:52 11/03/2024			Variaz. 5gg	Var. 1 gen.
4.300 ^JPY	-1,15%		-.--%	+8,18%

14/06	Takeda firma un accordo di opzione con Ascentage per la licenza di un farmaco contro la leucemia	MT
14/06	Takeda Pharmaceutical Company Limited firma un accordo di opzione con Ascentage Pharma per stipulare una licenza globale esclusiva per Olverembatinib, inibitore della tirosin-chinasi BCR-ABL di terza generazione	CI

Resoconti

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Transcript : Takeda Pharmaceutical Company Limited - Special Call	04/06
Transcript : Takeda Pharmaceutical Company Limited, 2024 Earnings Call, May 09, 2024	09/05
Transcript : Takeda Pharmaceutical Company Limited, Q3 2024 Earnings Call, Feb 01, 2024	01/02
Transcript : Takeda Pharmaceutical Company Limited Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 05:15 PM	09/01
Transcript : Takeda Pharmaceutical Company Limited, Q2 2024 Earnings Call, Oct 26, 2023	26/10/23
Transcript : Takeda Pharmaceutical Company Limited Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 03:55 PM	11/09/23
Transcript : Takeda Pharmaceutical Company Limited, Q1 2024 Earnings Call, Jul 27, 2023	27/07/23
Transcript : Takeda Pharmaceutical Company Limited, 2023 Earnings Call, May 11, 2023	11/05/23
Transcript : Takeda Pharmaceutical Company Limited - Special Call	19/03/23
Transcript : Takeda Pharmaceutical Company Limited - Special Call	16/03/23
Transcript : Takeda Pharmaceutical Company Limited Presents at Cowen 43rd Annual Healthcare Conference, Mar-06-2023 01:30 PM	06/03/23
Transcript : Takeda Pharmaceutical Company Limited, Q3 2023 Earnings Call, Feb 02, 2023	02/02/23
Transcript : Takeda Pharmaceutical Company Limited Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 04:30 PM	10/01/23
Transcript : Takeda Pharmaceutical Company Limited - Shareholder/Analyst Call	13/12/22
Transcript : Takeda Pharmaceutical Company Limited, Q2 2023 Earnings Call, Oct 27, 2022	27/10/22
Transcript : Takeda Pharmaceutical Company Limited - Special Call	04/10/22
Transcript : Takeda Pharmaceutical Company Limited Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-12-2022 02:50 PM	12/09/22
Transcript : Takeda Pharmaceutical Company Limited, Q1 2023 Earnings Call, Jul 28, 2022	28/07/22
Takeda Pharmaceutical Company Limited fornisce una previsione di guadagno consolidato per l'anno che termina il 31 marzo 2023	28/07/22	CI
Transcript : Takeda Pharmaceutical Company Limited, Q4 2022 Earnings Call, May 11, 2022	11/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Resoconti Takeda Pharmaceutical Company Limited Sapporo S.E.

Azioni

4502

JP3463000004

Resoconti

Filtri